Horan Capital Advisors LLC. Has $2.58 Million Position in CVS Health Corporation (CVS)
Horan Capital Advisors LLC. lifted its position in CVS Health Corporation (NYSE:CVS) by 3.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 32,115 shares of the pharmacy operator’s stock after buying an additional 1,000 shares during the quarter. CVS Health Corporation comprises approximately 1.8% of Horan Capital Advisors LLC.’s holdings, making the stock its 22nd biggest position. Horan Capital Advisors LLC.’s holdings in CVS Health Corporation were worth $2,584,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also recently added to or reduced their stakes in CVS. CGOV Asset Management lifted its holdings in CVS Health Corporation by 0.3% during the 1st quarter. CGOV Asset Management now owns 1,148,337 shares of the pharmacy operator’s stock valued at $120,090,000 after purchasing an additional 3,466 shares during the last quarter. Waldron LP lifted its holdings in CVS Health Corporation by 217.4% during the 1st quarter. Waldron LP now owns 10,633 shares of the pharmacy operator’s stock valued at $835,000 after purchasing an additional 7,283 shares during the last quarter. Canal Capital Management LLC acquired a new stake in CVS Health Corporation during the 1st quarter valued at $990,000. Advisor Partners LLC lifted its holdings in CVS Health Corporation by 23.4% during the 1st quarter. Advisor Partners LLC now owns 24,612 shares of the pharmacy operator’s stock valued at $1,932,000 after purchasing an additional 4,660 shares during the last quarter. Finally, Advisory Services Network LLC acquired a new stake in CVS Health Corporation during the 1st quarter valued at $868,000. 81.46% of the stock is owned by institutional investors and hedge funds.
CVS Health Corporation (CVS) opened at 76.49 on Friday. The company has a 50 day moving average price of $78.86 and a 200-day moving average price of $78.71. CVS Health Corporation has a 12 month low of $69.30 and a 12 month high of $88.58. The company has a market cap of $77.76 billion, a PE ratio of 15.24 and a beta of 0.92.
CVS Health Corporation (NYSE:CVS) last issued its quarterly earnings data on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.31 by $0.02. The business had revenue of $45.69 billion for the quarter, compared to analysts’ expectations of $45.36 billion. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The firm’s quarterly revenue was up 4.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.32 EPS. Equities analysts predict that CVS Health Corporation will post $5.88 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 3rd. Investors of record on Tuesday, October 24th will be issued a dividend of $0.50 per share. The ex-dividend date is Monday, October 23rd. This represents a $2.00 dividend on an annualized basis and a yield of 2.61%. CVS Health Corporation’s dividend payout ratio (DPR) is 39.92%.
CVS has been the subject of several research reports. Leerink Swann set a $90.00 price target on CVS Health Corporation and gave the company a “buy” rating in a report on Tuesday, June 27th. Needham & Company LLC initiated coverage on CVS Health Corporation in a report on Tuesday, June 27th. They set a “hold” rating for the company. Guggenheim reaffirmed a “buy” rating on shares of CVS Health Corporation in a report on Monday, July 3rd. Jefferies Group LLC reaffirmed a “hold” rating and set a $82.00 price target on shares of CVS Health Corporation in a report on Friday, July 14th. Finally, BidaskClub downgraded CVS Health Corporation from a “hold” rating to a “sell” rating in a report on Monday, July 24th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and sixteen have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $89.68.
COPYRIGHT VIOLATION WARNING: “Horan Capital Advisors LLC. Has $2.58 Million Position in CVS Health Corporation (CVS)” was reported by Daily Political and is the property of of Daily Political. If you are viewing this report on another site, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The legal version of this report can be viewed at https://www.dailypolitical.com/2017/10/22/horan-capital-advisors-llc-has-2-58-million-position-in-cvs-health-corporation-cvs.html.
In related news, Director Richard J. Swift sold 2,500 shares of the stock in a transaction dated Wednesday, August 16th. The stock was sold at an average price of $79.62, for a total transaction of $199,050.00. Following the sale, the director now owns 3,258 shares of the company’s stock, valued at approximately $259,401.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Thomas M. Moriarty sold 20,547 shares of the stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $81.17, for a total value of $1,667,799.99. Following the sale, the executive vice president now directly owns 43,178 shares in the company, valued at approximately $3,504,758.26. The disclosure for this sale can be found here. Insiders have sold a total of 716,625 shares of company stock worth $58,318,431 in the last three months. 0.61% of the stock is currently owned by insiders.
CVS Health Corporation Company Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.